Page 40 - Evogene Ltd News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Evogene (Evogene: EVGN) stock research, analysis, profile, news, analyst ratings, key statistics, fundamentals, stock price, charts, earnings, guidance and peers.

Based on the product, the market saw maximum growth in the biopesticides segment in 2020. What are the major trends in the market? Increasing governmental support for the use of bio-based products in agriculture is the major trend in the market. At what rate is the market projected to grow? The market is projected to grow at a CAGR of almost 15% during the forecast period. Who are the top players in the market? Agrinos AS, BASF SE, Bayer AG, Certis USA LLC, Evogene Ltd., Isagro Spa, Novozymes AS, Syngenta AG, UPL Ltd., and Valent BioSciences LLC are the top players in the market.

Evogene Financial Results and Earnings Announcement Schedule for the First Quarter of 2021 USA - English Share this article Share this article REHOVOT, Israel, May 12, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN) (TASE: EVGN), a leading computational biology company aiming to revolutionize life-science product development across several market segments, announces today that it will release its financial results for the first quarter of 2021 on Wednesday, May 26 th, 2021. Mr. Ido Dor, Chief Executive Officer of Evogene's subsidiary, Lavie Bio Ltd., will join the conference call to discuss...

Agricultural Biotechnology Market Revenue Worth $106,870 Million by 2030, says P&S Intelligence NEW YORK, April 29, 2021 /PRNewswire/ -- From 7.7 billion in 2019, the global population will reach 11.2 billion by 2100, according to the United Nations (UN). This is to be a key factor in the growth of the global agricultural biotechnology market revenue from $39,565.6 million in 2020 to $106,870.0 million by 2030, at a 10.7% CAGR between 2021 and 2030. This will be due to the burgeoning demand for food, which has already been putting immense pressure on the agrarian community for centuries. In a...

Evogene to Hold Virtual Investor & Analyst Days USA - English English language event on Wednesday, April 21, 2021 News provided by Share this article Share this article REHOVOT, Israel, April 7, 2021 /PRNewswire/ -- Evogene Ltd. (NASDAQ: EVGN), (TASE: EVGN), a leading computational biology company today announced that it will hold virtual investor and analyst days, in both Hebrew and English, via Zoom webinars. The meetings will feature key-note presentations from Evogene's CEO, Ofer Haviv, and the CEOs of Evogene group subsidiaries Biomica, Canonic, AgPlenus, and Lavie Bio, followed by a qu...